Skip to Content
Søk Menu

EHA | European Hematology Association

EHA 2025

The 2025 EHA Award Recipients

  • / Amanda Feldballe Bernholm

EHA 2025: ADHD Treatment medication alleviate Fatigue in Patients with Malignant Diseases show Danish Study

/ Hematologi / Henrik Frederiksen

Several Options for Frontline Treatment of MCL

/ Hematologi / Mats Jerkeman

EHA 2025: Durable Undetectable MRD Responses with Acalabrutinib in CLL

/ Hematologi / Paolo Ghia

EHA 2025: Signs of Functional Cure for MCL in 25 Years Nordic Follow-Up Study

/ Hematologi / Mats Jerkeman

EHA 2025: Sonrotoclax + Zanubrutinib Show Durable Responses in R/R CLL/SLL

/ Hematologi / Chan Cheah
Se oversigt

EHA 2024

Several Trials Showed Improvements in the Treatment of Multiple Myeloma

  • / BestPractice Nordic

Events | 2023

Gå till sidan

EHA 2024: One of the Most Important for Many Years

/ BestPractice Nordic
EHA24Lymfom

CLL: Needs At Least 10 Years of Follow-Up for Clinical Trials

/ BestPractice Nordic
CLLEHA24

The Development of New Treatment Options within AML Is Slower Than in Other Disease Areas within Hematology

/ BestPractice Nordic
AMLEHA24

New Data from EHA Shared and Discussed at Danish Evening

/ Jan Andreasen
EHA24
Maria Eugenia Chollet

Promising Avenues for the Development of Personalized Treatment for FVII Deficiency

/ Maria Eugenia Chollet
EHA24 Play the Video
Hanne Norseth

Vaccinating Against Mutated RAS in Multiple Myeloma

/ Hanne Norseth
EHA24Myelom Play the Video
Sergio Martinez Høyer

An Excellent Target with a Wide Therapeutic Window in del(5q) Myeloid Malignancies

/ Sergio Martinez Høyer
EHA24 Play the Video
Frida Bugge Askeland

Treating MRD Relapse After First-Line Treatment May Prolong PFS and OS in Myeloma Patients

/ Frida Bugge Askeland
EHA24Myelom Play the Video
Sigrid S. Skånland

From Genomic Precision Medicine to Functional Precision Medicine in Hematology

/ Sigrid S. Skånland
EHA24 Play the Video
Henrik Hjorth-Hansen

Management of CML in Adults: 2024 ELN Recommendations

/ Henrik Hjorth-Hansen
EHA24 Play the Video
Rasmus Rask Kragh Jørgensen

Development of Prediction Models for Survival among Hodgkin Lymphoma Patients

/ Rasmus Rask Kragh Jørgensen
EHA24Hodgkins lymfom Play the Video
Ângela Mesquita

Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes

/ Ângela Sofia Gerós Mesquita
EHA24 Play the Video
Load more

EHA 2023

Epcoritamab with Rituximab and Lenalidomide (R2) for Patients with High-Risk Follicular Lymphoma

/ Hematologi / Anna Sureda Balari

Belamaf and dexamethasone – Safe, effective multiple myeloma treatment

/ Hematologi / Evangelos Terpos / Jan Andreasen

Gilteritinib for Patients with Newly Diagnosed AML

/ Hematologi / Mark Levis

MURANO Study Supports the Use of Fixed-Duration VenR in R/R CLL

/ Hematologi / Arnon Kater

Daratumumab Combination Shows Positive Responses in Pretreated R/R Multiple Myeloma

/ Hematologi / Evangelos Terpos

News from EHA23 – A promising treatment option for follicular lymphoma

/ Hematologi / Ryan Jacobs

Risk of Dementia in Older Patients Treated with Chemotherapy for Lymphoma

/ Neurologi / Eva Futtrup Maksten

UK Trial Gives Voice to CLL Patients’ Experiences with Targeted Therapies

/ Hematologi / Dima El-Sharkawi

Promising Findings for R/R Large B-Cell Lymphoma – Glofitama and Epcoritamab Show Curative Potential

/ Onkologi / Martin Hutchings

New CLL Study Supports Inclusion of Venetoclax Plus Obinutuzumab in Treatment Guidelines

/ Hematologi / Othman Al-Sawaf
Se oversigt

Mer

Paolo Ghia

EHA 2025: Zanubrutinib Effective as First-Line CLL/SLL Therapy Regardless of del(17p)

/ Paolo Ghia
CLLEHA25 Play the Video
Hanne Norseth

EHA 2025: TG01 Shows Promise in KRAS-Mutated Myeloma

/ Hanne Norseth
EHA25Myelom Play the Video
Anne Louise Tølbøll Sørensen

EHA 2025: Nordic AML Group Explores Optimized Regimen for AML Patients

/ Anne Louise Tølbøll Sørensen
AMLEHA25 Play the Video
Frida Bugge Askeland

EHA 2025: Impact of Treating MRD Relapse Post 1L in Multiple Myeloma

/ Frida Bugge Askeland
EHA25Myelom Play the Video

The Missing Link of Light Chain Smoldering Multiple Myeloma

/ Sofie Pohl
Myelom
Jelena Jelicic

More Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Can Participate in Clinical Studies

/ Jelena Jelicic
EHA24Lymfom Play the Video
Load more
Back to top